Community Contributor
Member since 2020
Views
40k Total number of views
Fair Values Set
505 Total number of fair values set
Comments
2 Total number of comments
Followers
38 Total number of followers

This page is dedicated to uncovering and sparking thoughtful discussion around overlooked investment opportunities—primarily on the Australian Securities Exchange (ASX), with the occasional foray into compelling international markets.

No link added
AU$65
18.6% overvalued intrinsic discount
Fair Value
Revenue
2.48% p.a.
Profit Margin
6.6%
Future PE
32.89x
Price in 2031
AU$100.14
AU$73.8
18.0% undervalued intrinsic discount
Fair Value
Revenue
8.88% p.a.
Profit Margin
23.39%
Future PE
26.06x
Price in 2031
AU$108.96
US$404
25.6% overvalued intrinsic discount
Fair Value
Revenue
9.13% p.a.
Profit Margin
39.34%
Future PE
23.36x
Price in 2031
US$611.51
AU$7.96
17.0% undervalued intrinsic discount
Fair Value
Revenue
16.75% p.a.
Profit Margin
27.94%
Future PE
14.35x
Price in 2031
AU$11.78
UK£5.64
11.9% undervalued intrinsic discount
Fair Value
Revenue
8.65% p.a.
Profit Margin
23.04%
Future PE
10.2x
Price in 2031
UK£8.35
AU$16.3
2.6% overvalued intrinsic discount
Fair Value
Revenue
8.44% p.a.
Profit Margin
11.22%
Future PE
13.71x
Price in 2031
AU$24.45
COH logo
Cochlear

Cochlear’s Crossroads: Temporary Setback or Structural Shift?

Cochlear Limited is an interesting company. It is a medical technology business with a specific focus on implantable hearing solutions.Read more

View narrative
AU$70
91.9% overvalued intrinsic discount
Fair Value
Revenue
0.14% p.a.
Profit Margin
14.77%
Future PE
18.92x
Price in 2031
AU$100.4